## Abstract Articular cartilage tissue engineering procedures require the transplantation of chondrocytes that have been expanded __in vitro.__ The expansion is carried out for a considerable time and can lead to a modulation of cell phenotype. However, microcarrier cultures have been shown to allo
Farsenol-modified biodegradable polyurethanes for cartilage tissue engineering
✍ Scribed by David Eglin; Sibylle Grad; Sylwester Gogolewski; Mauro Alini
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 580 KB
- Volume
- 92A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A bifunctionalized 3,7,11‐trimethyl‐2,6,10‐dodecatrien‐1‐diaminobutane amide (isoprenoid) was obtained from 3,7,11‐trimethyl‐2,6,10‐dodecatrien‐1‐ol (farnesol) in a three‐step synthesis. The bifunctionalized isoprenoid was characterized using infrared spectroscopy and ^1^H and ^13^C nuclear magnetic resonance spectroscopy and was covalently incorporated (0.12 mmol.g^−1^) into the biodegradable aliphatic polyurethane formed on the polycondensation reaction of poly(ϵ‐caprolactone) diol, 1,4,3,6‐dianhydro‐D‐sorbitol and 1,6‐hexamethylene diisocyanate. Although the covalent incorporation of the isoprenoid molecule into the polyurethane chain modified the surface chemistry of the polymer, it did not affect the viability of attached chondrocytes. Porous 3D scaffolds were produced from the modified and unmodified biodegradable segmented polyurethanes by a salt leaching‐phase‐inverse technique. The scaffolds were seeded with bovine chondrocytes encapsulated in fibrin gel and cultured in vitro for 14 days. The incorporation of bifunctional isoprenoid into the polyurethane affected the morphology of the scaffolds produced, when compared with the morphology of the scaffolds produced using the same technique from the unmodified polyurethane. As a consequence, there was more uniform cell seeding and more homogeneous distribution of the synthesized extracellular matrix throughout the scaffold resulting in a reduced cell/tissue layer at the edges of the constructs. However, glycosaminoglycan (GAG), DNA content, and chondrocytes phenotype in the scaffolds produced from these two polyurethane formulations did not vary significantly. The findings suggest that the change of surface characteristics and the more open pore structure of the scaffolds produced from the isoprenoid‐modified polyurethane are beneficial for the seeding efficiency and the homogeneity of the tissue engineered constructs. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010
📜 SIMILAR VOLUMES
## Abstract **Summary:** A novel process was developed to fabricate biodegradable polymer scaffolds for tissue engineering applications, without using organic solvents. Solvent residues in scaffolds fabricated by processes involving organic solvents may damage cells transplanted onto the scaffolds
## Abstract The objective of this study is to assess whether a new biodegradable elastomer, poly(1,8‐octanediol citrate) (POC), would be a suitable material to engineer elastomeric scaffolds for cartilage tissue engineering. Porous POC scaffolds were prepared via the salt‐leaching method and initia
## Abstract A novel, nontoxic, biodegradable, sponge‐like polyurethane scaffold was synthesized from lysine‐di‐isocyanate (LDI) and glycerol. Ascorbic acid (AA) was copolymerized with LDI‐glycerol. Our hypothesis was that the AA‐containing polymer foam would enhance the biological activity of the o
## Abstract Cartilage tissue engineering based on cultivation of immature chondrocytes in agarose hydrogel can yield tissue constructs with biomechanical properties comparable to native cartilage. However, agarose is immunogenic and nondegradable, and our capability to modify the structure, composi